retatrutide where to but inject retatrutide: complete injection site guide for safe administration Retatrutide (Reta GLP-3) - 99%+

Dosing fundamentals Administration: Once weekly subcutaneous injection Same day each week (consistency matters) Preferably at the same time of day Half-life: Approximately 6 days, supporting weekly dosing Dose escalation: Every 4 weeks, unless: Side effects require holding current dose Individual tolerance suggests faster/slower progression Healthcare provider recommends adjustment Clinical trial doses tested The Phase 2 obesity trial tested multiple dosing arms: Key insight: 8 mg produces nearly the same results as 12 mg with fewer side effectsmaking it a potential "sweet spot" for many users

Post-treatment care Proper aftercare optimizes results and minimizes complications

smarter metabolic support

The psychological burden Many patients expect improved health to be matched by a fresher appearance

Retrieved from Novo Nordisk-f